Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome

The case of thiamine‐responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow‐up, and regulated treatment plan for the patients. Complications and systemic manifestations are likely to enhance in otherwise circumstances.

Detalles Bibliográficos
Autores principales: Faraji‐Goodarzi, Mojgan, Tarhani, Fariba, Taee, Nadereh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303871/
https://www.ncbi.nlm.nih.gov/pubmed/32577249
http://dx.doi.org/10.1002/ccr3.2791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303871/
https://www.ncbi.nlm.nih.gov/pubmed/32577249
http://dx.doi.org/10.1002/ccr3.2791

Ejemplares similares